Campo Mártires da Pátria, 130. 1169-056 Lisboa – Portugal
Phone: 218803100 Ext: 26047

João Conde

Researcher Investigador Principal
Deputy Director for Research

João Conde is an Assistant Professor and Group Leader of the Cancer Nanomedicine group at NOVA Medical School, Universidade Nova de Lisboa, ToxOmics. He is also co-founder of the biotech company TargTex, Targeted Therapeutics for Glioblastoma Multiforme. He is also part of the Global Burden of Disease (GBD) Consortium, IHME - University of Washington.

“Prodrug polymeric nanoconjugates encapsulating gold nanoparticles for enhanced X-Ray radiation therapy in breast cancer” H. Nosrati, F. Seidi, A. Hosseinmirzaei, N. Mousazadeh, A. Mohammadi, Mo. Ghaffarlou, H. Danafar, João Conde* and Ali Sharafi*. Advanced Healthcare Materials - Rising Star Issue (2021).

“Controlled delivery of gold nanoparticle-coupled miRNA therapeutics via an injectable self-healing hydrogel”. C.F.T. van der Ven, M.W. Tibbitt, João Conde, A. van Mil, J. Hjortnaes, P.A.F.M. Doevendans, J.P.G. Sluijter, E. Aikawa and Robert Langer. Nanoscale (2021) - Featured on COVER

“The global burden of adolescent and young adult cancer in 2019: An analysis of the Global Burden of Disease Study 2019”. João Conde & GBD Consortium. The Lancet Oncology (2021) - Featured on COVER

“Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups from 2010 to 2019: A Systematic Analysis of Cancer Burden Globally, Nationally, and by Socio-Demographic Index for the Global Burden of Disease Study 2019”. João Conde & GBD Consortium. JAMA Oncology (2021).

“Machine-readable Nanotechnology for future healthcare research”. Andzelika Lorenc, Bárbara B. Mendes, João Conniot, Diana P. Sousa, João Conde* and Tiago Rodrigues*. Matter (Cell Press) (2021).

“Global, regional, and national progress toward Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019” GBD Consortium. The Lancet (2021).

“Facts and Figures on Materials Science and Nanotechnology Progress and Investment”. S. Talebian, T. Rodrigues, J. das Neves, B. Sarmento, R. Langer, João Conde*. ACS Nano (2021)

“Nanotechnology-based strategies to target and modulate the tumor microenvironment”. Barbara Mendes, João Conniot, Diana Sousa, João Conde*. Trends in Cancer (2021). Featured on COVER.

“Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression”. João Conde, R.A. Pumroy, C. Baker, T. Rodrigues, A. Guerreiro, B.B. Sousa, M.C. Marques, B.P. de Almeida, S. Lee, E.P. Leites, D. Picard, A. Samanta, S.H. Vaz, F. Sieglitz, M. Langini, M. Remke, R. Roque, T. Weiss, M. Weller, Y. Liu, S. Han, F. Corzana, V.A. Morais, C.C. Faria, T. Carvalho, P. Filippakopoulos, B. Snijder, N.L. Barbosa-Morais, V.Y. Moiseenkova-Bell, G.J.L. Bernardes. ACS Central Science (2021) Featured on COVER.

“Revisiting Gene Delivery to the Brain: Silencing and Editing” (2021 Biomaterials Science Emerging Investigators Issue). João Conniot, Sepehr Talebian, Susana Simões, Lino Ferreira*, João Conde*. Biomaterials Science (2020) Featured on COVER.

“Why Go NANO on COVID-19 pandemic?”. Sepehr Talebian and João Conde*. Matter (2020).

“Nanotechnology-based disinfectants and sensors for SARS-CoV-2” S. Talebian, G.G. Wallace, A. Schroeder, F. Stellacci and João Conde*. Nature Nanotechnology (2020) COVID-19 Special Issue.

“Localized Nanotheranostics: Recent developments in Cancer Nanomedicine”. R. Prasad, N.K. Jain, João Conde*, R. Srivastava. Materials Today Advances (2020)

“Above and beyond Cancer Therapy: translating biomaterials into clinics” João Conde* Trends in Cancer (2020).

“Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model”. João Conde*, N. Oliva, Y. Zhang and N. Artzi. Nature Materials (2016). Highlighted in Science Translational Medicine and Science Bulletin.

“Local microRNA delivery targets Palladin and prevents metastatic breast cancer”. A. Gilam, João Conde, D. Weissglas-Volkov, N. Oliva, N. Artzi, N. Shomron. Nature Communications (2016).

“Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment”. João Conde*, N. Oliva, M. Atilano, H.S.  H.S. Song, N. Artzi. Nature Materials (2016). Highlighted in Science Translational Medicine and The Scientist.

“Implantable hydrogel embedded dark-gold nanoswitch as a theranostics probe to sense and overcome cancer multidrug resistance”. João Conde*, N. Oliva, N. Artzi. PNAS (2015). Highlighted in Nature Reviews Drug Discovery.

• 2021 - Nanomaterials 2020 Young Investigator Award, MDPI.

• 2021 - Top2% Most Cited Researchers in Nanoscience and Nanotechnologies, PLOS Biology.

• 2021 - 2021 Biomaterials Science Emerging Investigators, Royal Society of Chemistry.

• 2019 - ERC Starting Grant: ERC-StG-2019-848325, European Research Council, EU.

• 2018 - Junior Investigator: FCT Stimulus of Scientific Employment, (CEECIND/01688/2017) National Science Foundation, PT.

• 2017 - Wellcome Image Awards 2017: Wellcome Trust, UK.

• 2016 - Nano-Micro Letters Researcher Award, Nature Research Society.

• 2016 - National Cancer Institute Image award: Cancer close up, USA.

• 2013 - Marie Curie International Outgoing Fellowship for Career Development, Marie Skłodowska-Curie actions (FP7-PEOPLE-2013-IOF).

• 2009 - PhD Fellowship - National Science Foundation - PhD Grant (FCT, SFRH/BD/ 62957/2009), PT.